The Food and Drug Administration (“FDA”) has greatly increased its activity around cybersecurity initiatives and medical devices. As we approach the end of the year, this is a great opportunity to review recent developments.
FDA Medical Device Cybersecurity Guidance
On October 18, 2018, the FDA published draft guidance, “Content of Premarket Submissions for Management of
Latest from Squire Patton Boggs - Page 23
New EU Strategy on Artificial Intelligence
On Wednesday 25 April, the EU Commission unveiled a new strategy to boost Europe’s capabilities and related industries around artificial intelligence. As you know, this is a “hot topic” that has the potential to affect many businesses and sectors across Europe and beyond. Many of our clients are very interested in this technology development (and
The Malicious Use Of AI – Why Those “Black Mirror” Scenarios May Be Closer Than We Think
Developments in artificial intelligence (AI) are proving hugely beneficial for society, both at a commercial and individual level (e.g. face recognition and medical diagnostic technology, route mappers for navigation, robotic pets, cleaners and industrial robots). However, with the advancement of such technology, and the increasing integration of AI into our everyday lives, comes the potential
Proposed CFIUS Law Will Impose New Export Controls on US Businesses
The Foreign Investment Risk Review Modernization Act of 2017 (S. 2098/H.R. 4311, FIRRMA for short) was introduced in Congress to reform the national security review of foreign acquisitions of US businesses by the Committee on Foreign Investment in the United States (CFIUS or the Committee). However, FIRRMA extends well beyond this purpose of reviewing acquisitions